Ophthalmological composition of the type which undergoes liquid-gel phase transition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4861760
SERIAL NO

06911606

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • LABORATOIRES MERCK SHARP & DOHME-CHIBRET;MERCK & CO., INC.;CHIBRET INTERNATIONAL, SA;LABORATOIRES MERCK SHARP & DOHME-CHIBRET, A CORP. OF FRANCE

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Friteyre, Marie-Claire Riom, FR 1 335
Mazuel, Claude Riom, FR 2 342

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation